ALDX   $4.86  1.04% Market Closed After Close 4.85 -0.21%

Aldeyra Therapeutics Inc
Total Cash 80.33M
totalCashPerShare 1.352
EBITDA -42.80M
Total Debt 15.64M
quickRatio 2.911
currentRatio 4.553
Total Revenue
debtToEquity 15.905
Revenue/Share
ROA -0.19105
ROE -0.33191
grossProfits
freeCashflow -63.45M
operatingCashflow -30.72M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 248.46M
forwardPE -8.107693
floatShares 43.13M
sharesOutstanding 59.42M
sharesShort 3.40M
sharesShortPriorMonth 2.98M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.60%
Short Ratio help_outline 7.52%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 1.655
Price To Book help_outline 3.18
earningsQuarterlyGrowth
netIncomeToCommon -37.87M
trailingEps -0.64%
forwardEps -0.65%
enterpriseToEbitda -5.81
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 144
lastUpdated Nov. 6, 2024, 5:22 p.m.